| Filed On | Filing |
|---|---|
| 19 Oct 2026 |
8-K: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
150023820.2 AMENDED AND RESTATED BYLAWS OF AQUESTIVE THERAPEUTICS, INC. (As of October 1516[●], 20242026) ARTICLE I STOCKHOLDERS Section 1. The annual meeting of the stockholders of Aquestive Therapeutics, Inc. (the “Corporation”) for th... |
| 15 Oct 2026 |
8-K: Regulation FD Disclosure
Aquestive Therapeutics Announces FDA Acceptance of Anaphylm™ NDA Resubmission and PDUFA Goal Date of March 16, 2027 • FDA accepted the resubmission as complete and classified it as a Class 2 response • Prescription Drug User Fee Act (PDU... |
| 14 Oct 2026 |
8-K: Entry into a Material Definitive Agreement
Eton Pharmaceuticals and Aquestive Therapeutics Announce Exclusive U.S. Licensing Agreement for LIBERVANT® (diazepam) Buccal Film • Differentiated, portable buccal film would offer patients and caregivers an alternative to existing nasal... |
| 29 Sep 2026 |
8-K: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Aquestive Therapeutics Strengthens Board of Directors with Appointment of Richard Daly Appoints Rich Daly, a life sciences executive with more than 30 years of leadership experience across large pharmaceutical companies, emerging biotech... |
| 25 Sep 2026 |
8-K: Regulation FD Disclosure
Disclaimer This presentation and the accompanying oral commentary have been prepared by Aquestive Therapeutics, Inc. (“Aquestive,” the “Company,” “we,” “our” or “us”) and contain “forward-looking statements” within the meaning of the Pri... |
| 17 Sep 2026 |
8-K: Regulation FD Disclosure; Other Events
H.C. Wainwright 28th Annual Global Investment Conference September 14, 2026 |
| 11 Aug 2026 | 8-K: Results of Operations and Financial Condition; Regulation FD Disclosure |
| 10 Aug 2026 | 8-K: Regulation FD Disclosure; Other Events |
| 10 Jun 2026 | 8-K: Submission of Matters to a Vote of Security Holders |
| 13 May 2026 | 8-K: Entry into a Material Definitive Agreement; Termination of a Material Definitive Agreement +4 more |
| 30 Mar 2026 | 8-K: Regulation FD Disclosure |
| 20 Mar 2026 | 8-K: Departure/Election of Directors or Officers; Compensation; Regulation FD Disclosure |
| 04 Mar 2026 | 8-K: Entry into a Material Definitive Agreement; Results of Operations and Financial Condition +2 more |
| 26 Feb 2026 | 8-K: Regulation FD Disclosure |
| 02 Feb 2026 | 8-K: Regulation FD Disclosure |
| 09 Jan 2026 | 8-K: Other Events |
| 06 Nov 2025 | 8-K: Regulation FD Disclosure |
| 05 Nov 2025 | 8-K: Results of Operations and Financial Condition; Regulation FD Disclosure |
| 08 Oct 2025 | 8-K: Other Events |
| 01 Oct 2025 | 8-K: Regulation FD Disclosure |
Loading...
